Following an extensive search of industry and academic professionals by The Chase Group, the Allen Institute for Immunology welcomes a new Director, Informatics & Computational Biology. The Director brings a comprehensive background of academic, industry, and leadership experience to the Institute’s large-scale and dedicated research effort. Committed to unraveling the mysteries of the immune system, the Institute for Immunology is on a mission to advance the fundamental understanding of human immunology through the study of immune health and diseases. By leading the Bioinformatics and Computational Biology team in creating multiple data streams and through the integration of the data analysis pipeline for the overall Institute, this critical hire will be a key role in the Institute’s ability to improve diagnosis, treatment, and prevention of immune-related diseases at a scale of unparalleled precision. The Chase Group does not lose sight of the profound impact placements have on the future success of partnered organizations. The goal is to strive for the best possible result for both the candidate and the company, connecting life-changing organizations and executives. For more information about this role or how The Chase Group can assist with your next hire, please contact ken@chasegroup.com.
The Chase Group Secures New Leader for Informatics & Computational Biology at the Allen Institute for Immunology
Following an extensive search of industry and academic professionals by The Chase Group, the Allen Institute for Immunology welcomes a new Director, Informatics & Computational Biology. The Director brings a comprehensive background of academic, industry, and leadership experience to the Institute’s large-scale and dedicated research effort. Committed to unraveling the mysteries of the immune system, the Institute for Immunology is on a mission to advance the fundamental understanding of human immunology through the study of immune health and diseases. By leading the Bioinformatics and Computational Biology team in creating multiple data streams and through the integration of the data analysis pipeline for the overall Institute, this critical hire will be a key role in the Institute’s ability to improve diagnosis, treatment, and prevention of immune-related diseases at a scale of unparalleled precision. The Chase Group does not lose sight of the profound impact placements have on the future success of partnered organizations. The goal is to strive for the best possible result for both the candidate and the company, connecting life-changing organizations and executives. For more information about this role or how The Chase Group can assist with your next hire, please contact ken@chasegroup.com.- Categories: Life Sciences, Research & Development
The Chase Group Secures Clinical Operations Leadership for Alexza Pharmaceuticals
The Chase Group, committed to executive recruitment in life sciences, is pleased to announce the completion of another search for Alexza Pharmaceuticals, successfully securing Mike…
Arcturus Therapeutics Secures Head of Drug Safety Through Continued Partnership with The Chase Group
The Chase Group’s track record for success continues with another executive placement secured for Arcturus Therapeutics. Entering a new stage in clinical development, Arcturus retained…
Leadership Team Grows at Biologics Consulting Through Partnership with The Chase Group
Biologics Consulting, currently experiencing a season of growth, retained The Chase to build out their leadership team. Tasked with identifying a Regulatory Project Management Lead,…-
The Chase Group Successfully Completes Search for Vice President, Research & Development at Alexza Pharmaceuticals
Alexza Pharmaceuticals stands at the crossroads of innovation and advanced technology with a platform that has the potential to address unmet medical needs in neuroscience…. -
The Chase Group Successfully Places David Geller, MD as Head of Pulmonary & Rare Disease Clinical Development for Arcturus Therapeutics
The Chase Group (TCG) is pleased to announce the successful recruitment of David Geller, MD as the Vice President, Pulmonary and Rare Diseases Clinical Development… 
Drug Safety Leadership Team Grows at Ionis Pharmaceuticals Through Continued Partnership with The Chase Group
Ionis Pharmaceuticals retained The Chase Group to identify and secure the next member of their drug safety leadership team to support a robust and continually…